person · Reporting owner

HERRERA GUILLERMO A

Disclosed activity across 1 company

Tapewire entity: 17688
SEC CIK: 0001242826

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ABBOTT LABORATORIESABT · Entity 2314	Senior Vice President	February 20, 2004	February 24, 2004

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ABBOTT LABORATORIES

Report date February 20, 2004 · Filed February 24, 2004

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common shares without par valueSEC Table I · non-derivative	Direct	107,979	Reported balance After 2004-02-20 transaction · row 1 1 source row Row 1 · 2004-02-20 · Grant · Acquired 8,000 · Balance 107,979 F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.66 · Expires 2014-02-19	Direct	55,000	Reported balance After 2004-02-20 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2004-02-20 · Grant · Acquired 55,000 · Balance 55,000 F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07.
Common shares without par valueSEC Table I · non-derivative	IndirectProfit Sharing Trust	23,622	Reported balance Holding disclosure · report date 2004-02-20 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 23,622 F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2004.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2004.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 20, 2004 Filed Feb 24, 2004 21:15 UTC	ABBOTT LABORATORIES ABT · Entity 2314	GrantOption (right to buy) · Derivative	55,000	$0.00 Strike: $43.66	$0.00	Disclosure SEC source: 0001104659-04-005604 · a4.xml · derivative · entry 3 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: common shares · 55,000 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07. Read SEC document
February 20, 2004 Filed Feb 24, 2004 21:15 UTC	ABBOTT LABORATORIES ABT · Entity 2314	GrantCommon shares without par value	8,000	$43.66	$349,280.00	Disclosure SEC source: 0001104659-04-005604 · a4.xml · nonDerivative · entry 1 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,979 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document
September 23, 2003 Filed Feb 13, 2004 20:01 UTC	ABBOTT LABORATORIES ABT · Entity 2314	Giftcommon shares without par value	125	$0.00	$0.00	Disclosure SEC source: 0001104659-04-004262 · a5.xml · nonDerivative · entry 1 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,979 Read SEC document
June 30, 2003 Filed Jul 2, 2003 18:57 UTC	ABBOTT LABORATORIES ABT · Entity 2314	GrantOption (right to buy) · Derivative	12,082	$0.00 Strike: $43.60	$0.00	Disclosure SEC source: 0001104659-03-013876 · j2761_4.xml · derivative · entry 4 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,082 Underlying: Common shares · 12,082 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document
June 30, 2003 Filed Jul 2, 2003 18:57 UTC	ABBOTT LABORATORIES ABT · Entity 2314	Exercise / conversionOption (right to buy) · Derivative	13,785	$0.00 Strike: $34.70	$0.00	Disclosure SEC source: 0001104659-03-013876 · j2761_4.xml · derivative · entry 3 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 Underlying: Common shares · 13,785 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 30, 2003 Filed Jul 2, 2003 18:57 UTC	ABBOTT LABORATORIES ABT · Entity 2314	Tax withholdingCommon shares without par value	12,082	$43.60	$526,775.20	Disclosure SEC source: 0001104659-03-013876 · j2761_4.xml · nonDerivative · entry 2 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,104 F1 · balance_after: The reporting person also owns 23,220 shares indirectly through the Abbott Laboratories Stock Retirement Trust as of June 30, 2003. Read SEC document
June 30, 2003 Filed Jul 2, 2003 18:57 UTC	ABBOTT LABORATORIES ABT · Entity 2314	Exercise / conversionCommon shares without par value	13,785	$34.70	$478,339.50	Disclosure SEC source: 0001104659-03-013876 · j2761_4.xml · nonDerivative · entry 1 HERRERA GUILLERMO A · CIK 0001242826 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.